THRESHOLD PHARMACEUTICAL INC's ticker is THLD and the CUSIP is 885807206. A total of 36 filers reported holding THRESHOLD PHARMACEUTICAL INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $2,788,000 | -31.0% | 7,093,802 | 0.0% | 0.01% | -30.0% |
Q1 2017 | $4,043,000 | +29.3% | 7,093,802 | 0.0% | 0.01% | +25.0% |
Q4 2016 | $3,128,000 | -22.7% | 7,093,802 | +18.7% | 0.01% | -20.0% |
Q3 2016 | $4,048,000 | +99.1% | 5,974,802 | +86.7% | 0.01% | +100.0% |
Q2 2016 | $2,033,000 | -0.1% | 3,199,433 | +539.9% | 0.01% | 0.0% |
Q3 2015 | $2,035,000 | -60.4% | 500,000 | -60.7% | 0.01% | -58.3% |
Q2 2015 | $5,134,000 | -10.0% | 1,270,768 | -9.6% | 0.01% | -14.3% |
Q1 2015 | $5,707,000 | +30.3% | 1,405,768 | +2.1% | 0.01% | +27.3% |
Q4 2014 | $4,380,000 | +11.1% | 1,377,448 | +26.2% | 0.01% | +10.0% |
Q3 2014 | $3,941,000 | +24.4% | 1,091,700 | +36.5% | 0.01% | +25.0% |
Q2 2014 | $3,168,000 | -4.9% | 800,000 | +14.3% | 0.01% | -11.1% |
Q1 2014 | $3,332,000 | +256.7% | 700,000 | +250.0% | 0.01% | +200.0% |
Q4 2013 | $934,000 | +0.4% | 200,000 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $930,000 | -11.6% | 200,000 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $1,052,000 | – | 200,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 625,558 | $2,540,000 | 1.95% |
CG Asset Management LLC | 128,000 | $520,000 | 0.20% |
Rotella Capital Management, Inc. | 45,364 | $184,000 | 0.15% |
TFS CAPITAL LLC | 348,617 | $1,415,000 | 0.14% |
Rhenman & Partners Asset Management AB | 201,537 | $818,000 | 0.14% |
FORTALEZA ASSET MANAGEMENT INC/ | 59,180 | $240,000 | 0.14% |
Baker Brothers Advisors | 2,925,519 | $11,878,000 | 0.10% |
FEDERATED HERMES, INC. | 3,918,305 | $15,908,000 | 0.05% |
FRANKLIN STREET ADVISORS INC /NC | 50,000 | $203,000 | 0.04% |
Princeton Alpha Management LP | 26,560 | $108,000 | 0.02% |